deltatrials
Completed OBSERVATIONAL NCT01773655

Clinical and Histopathologic Characteristics of BAP1 Mutations

Sponsor: Memorial Sloan Kettering Cancer Center

Conditions Cholangiocarcinoma Choroidal Nevus Malignant Pleural Mesothelioma (MPM) Metastatic Uveal Melanoma (UM) Primary Uveal Melanoma (UM) Renal Cell Carcinoma
Interventions tumor specimens
Updated 15 times since 2017 Last updated: Jun 30, 2020 Started: Jan 31, 2013 Primary completion: Jun 30, 2020 Completion: Jun 30, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Cholangiocarcinoma and Choroidal Nevus, this trial is completed. The trial is conducted by Memorial Sloan Kettering Cancer Center and has accumulated 15 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshot~Dec 2018 – ~Apr 2019 · 4 months · monthly snapshot~Apr 2019 – ~Apr 2020 · 12 months · monthly snapshot~Apr 2020 – ~Jul 2020 · 3 months · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Nov 2020 · 3 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Dec 2021 — Jul 2024 [monthly]

    Completed

  4. Jan 2021 — Dec 2021 [monthly]

    Completed

  5. Nov 2020 — Jan 2021 [monthly]

    Completed

▶ Show 10 earlier versions

  1. Aug 2020 — Nov 2020 [monthly]

    Completed

    Status: Active Not Recruiting → Completed

  2. Jul 2020 — Aug 2020 [monthly]

    Active Not Recruiting

  3. Apr 2020 — Jul 2020 [monthly]

    Active Not Recruiting

  4. Apr 2019 — Apr 2020 [monthly]

    Active Not Recruiting

  5. Dec 2018 — Apr 2019 [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

  6. Jun 2018 — Dec 2018 [monthly]

    Recruiting

  7. May 2018 — Jun 2018 [monthly]

    Recruiting

  8. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  9. Aug 2017 — Apr 2018 [monthly]

    Recruiting NA

  10. Jan 2017 — Aug 2017 [monthly]

    Recruiting NA

    First recorded

Jan 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Memorial Sloan Kettering Cancer Center
  • United States Department of Defense
Data source: Memorial Sloan Kettering Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations